Rockwell Medical to Release Second Quarter 2024 Results on Thursday, August 8, 2024
Rockwell Medical (Nasdaq: RMTI) announced it will release its financial and operational results for the second quarter of 2024 on August 8, 2024. The announcement will be made at 6:00am ET, followed by a live conference call and webcast at 8:00am ET. Rockwell Medical, a healthcare company specializing in hemodialysis products, will discuss the financial and operational results for the quarter ending June 30, 2024, and hold a Q&A session. The conference can be accessed via phone at (888) 660-6347 (domestic) or (929) 201-6594 (international) using Conference Call ID: 4944610, or via webcast at www.RockwellMed.com/Results.
- Announcement of financial and operational results for Q2 2024.
- None.
CONFERENCE CALL AND WEBCAST DETAILS
Date: Thursday, August 8, 2024
Time: 8:00am ET
Live Number: (888) 660-6347 // (International) 1 (929) 201-6594
Conference Call ID: 4944610
Webcast and Replay: www.RockwellMed.com/Results
Format: Discussion of second quarter 2024 financial and operational results followed by Q&A.
ABOUT ROCKWELL MEDICAL
Rockwell Medical, Inc. (Nasdaq: RMTI) is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers worldwide. Rockwell Medical's mission is to provide dialysis clinics and the patients they serve with the highest quality products supported by the best customer service in the industry. Rockwell is focused on innovative, long-term growth strategies that enhance its products, its processes, and its people, enabling the Company to deliver exceptional value to the healthcare system and provide a positive impact on the lives of hemodialysis patients. Hemodialysis is the most common form of end-stage kidney disease treatment and is usually performed at freestanding outpatient dialysis centers, at hospital-based outpatient centers, at skilled nursing facilities, or in a patient’s home. Rockwell Medical's products are vital to vulnerable patients with end-stage kidney disease, and the Company is relentless in providing unmatched reliability and customer service. Rockwell Medical is the largest supplier of liquid bicarbonate concentrates and the second largest supplier of acid and dry bicarbonate concentrates for dialysis patients in
View source version on businesswire.com: https://www.businesswire.com/news/home/20240711847157/en/
Heather R. Hunter
SVP, Chief Corporate Affairs Officer
(248) 432-1362
IR@RockwellMed.com
Source: Rockwell Medical, Inc.
FAQ
When will Rockwell Medical release its second quarter 2024 financial results?
What time will Rockwell Medical announce its Q2 2024 results?
How can I access the Rockwell Medical Q2 2024 earnings call?
What is the stock symbol for Rockwell Medical?
What will be discussed during Rockwell Medical's Q2 2024 conference call?